Science statins over 50

Published on May 17th, 2012 | by Kim LaCapria

0

Statins Examined For Healthy Adults, Recommended in New Meta-Analysis





statins over 50

A new meta-analysis of existing data has suggested that even healthy adults over the age of 50 should perhaps be regularly taking the medications known as statins, or cholesterol-reducing drugs, given their clear risk to benefit ratio.

Researchers say statins could save “a lot of lives” if used in “apparently healthy people with no previous history of heart disease,” where the drugs cut risk of heart attack or stroke by a fifth. Researchers from the University of Oxford in England looked at the impact of statins in populations suffering from heart disease as well as those with no apparent health problems, and discovered that the benefits of statin therapy in those over 50 outweighs any known risks associated with the medications.

Data from about 175,000 participants across 27 studies was culled for the meta-analysis led by Professor Colin Baigent of Oxford. Baigent commented:

“This benefit [of reduced death risk] greatly exceeds any known hazards of statin therapy… Under present guidelines, such individuals would not typically be regarded as suitable for LDL-lowering statin therapy. The present report suggests, therefore, that these guidelines might need to be reconsidered.”

The meta-analysis of statins was published Wednesday in medical journal The Lancet.

Comments

comments

Tags: , , , ,



About the Author

Kim LaCapria is a writer and editor based in New York. A longtime information junkie, she began blogging full-time at the Inquisitr in 2009. Prior to that, she worked as a marketing assistant in the cosmetics and skincare industry. In addition to her writing for fortytwotimes, she also writes for Medacity and The Inquisitr. Kim is also a contributor for SocialNewsDaily, Indyposted, and TotallyMoney. In the past, she contributed to Lipstick and Luxury and managed social media accounts and blogs for several small and mid-sized businesses.



Comments are closed.

Back to Top ↑